CYTK vs TSN · rev $28.6M vs P/E 22, rev $54.44B
Cytokinetics Inc (CYTK) versus Tyson Foods Inc (TSN) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Tyson Foods Inc (TSN) is a farm products company listed on US.
Latest reported CYTK revenue for 2026-06-30 was $28.6M. Net income was -$198.8M. Revenue was up 47.9% from 2026-03-31 to 2026-06-30. CYTK currently screens at market cap $4.05B.
Latest reported TSN revenue for 2025-09-27 was $54.44B. Net income was $507.0M. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
CYTK currently screens at market cap $4.05B. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
Not investment advice. Open the CYTK and TSN stock pages for the full models.
Not investment advice.